The Discounted Cash Flow (DCF) valuation of BRAIN Biotechnology Research and Information Network AG (BNN.DE) is (8.87) EUR. With the latest stock price at 1.97 EUR, the upside of BRAIN Biotechnology Research and Information Network AG based on DCF is -551.2%.
Based on the latest price of 1.97 EUR and our DCF valuation, BRAIN Biotechnology Research and Information Network AG (BNN.DE) is a sell. selling BNN.DE stocks now will result in a potential gain of 551.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 6.7% | 6.0% |
| Long-term Growth Rate | 3.0% - 4.9% | 3.9% |
| Fair Price | (50.26) - (4.88) | (8.87) |
| Upside | -2657.9% - -348.3% | -551.2% |